GLB
+0.0 · +0.00%
EUR · LSE

Glanbia plc(GLB) Stock Analysis | Consumer Defensive

EUR --+0.00%
Reward41Moderate
Risk28Low
75%Data
2.4% dividend yield
Capital Destroyer
Market Cap:5.52Bn
ⓘ
Reward Rating
41
Moderate
Reward Assessment
75% data coverage
Bottom 10% of stocksView factors
ⓘ
Risk Rating
28
Low
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on GLB to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for GLB, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: €15.90.

What is Glanbia plc?

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide.

GLB · Verdict

Moderate reward · low risk

GLB stands out on volatility and cash flow, but watch the growth signal.

Based on 88% data coverage

GLB · Verdict

What’s working & what to watch

Strengths 3

  • Volatility80/100

    Top decile vs peers

  • Cash flow67/100

    8% free-cash-flow margin

  • Balance sheet66/100

    Interest covered 11.0×

Watchouts 2

  • Growth33/100

    Rev -10.0% CAGR · earnings -1.5%

  • Valuation40/100

    P/E 16.5× · PEG 9.08

Model-based scoring. For information only — not financial advice.

What is Glanbia plc?

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. The company is listed on the LSE in UK, operating in the Consumer Defensive sector, with a market capitalisation of 5.52B, and a P/E ratio of 0.3x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Profitability metrics are mixed — margins may be under pressure.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Packaged Foods names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorConsumer Defensive
IndustryPackaged Foods
Market Cap5.52B
P/E Ratio0.2699
Dividend Yield2.36%
Beta0.499
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.